Arbutus Biopharma (ABUS) Asset Utilization Ratio (2014 - 2026)

Arbutus Biopharma has disclosed Asset Utilization Ratio across 13 years of filings, most recently posting 1.03 for Q1 2026.

• Asset Utilization Ratio for Q1 2026 came in at 1.03, up 1900.22% year-over-year; the trailing twelve-month figure through Mar 2026 was 1.03 (up 1900.22% YoY), and the FY2025 annual result was 0.12, up 178.41% from the prior year.
• Asset Utilization Ratio came in at 1.03 for Q1 2026 at Arbutus Biopharma, up from 0.15 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 1.03 in Q1 2026 to a low of 0.04 in Q3 2024.
• The 5-year median for Asset Utilization Ratio is 0.13 (2023), against an average of 0.17.
• Across the five-year window, Asset Utilization Ratio plunged 66.16% in 2024 and soared 1900.22% in 2026, its largest moves.
• Arbutus Biopharma's Asset Utilization Ratio stood at 0.2 in 2022, then tumbled by 38.75% to 0.12 in 2023, then plunged by 62.12% to 0.05 in 2024, then jumped by 222.93% to 0.15 in 2025, then jumped by 603.24% to 1.03 in 2026.
• The last three Asset Utilization Ratio figures came in at 1.03 (Q1 2026), 0.15 (Q4 2025), and 0.15 (Q3 2025), per Business Quant data.